CD8A and neoplasm: Another small molecule AhR inhibitor—BAY218, used in the murine model—reduced tumor growth and enhanced immune response by increasing the infiltration of CD8+ T and NK cells with simultaneous reduction with regard to suppressive GR1+ myeloid cells and M2 macrophages [223].